All Stories

  1. Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

    Article • Multiple Sclerosis Journal, May 2018, SAGE Publications

    Gavin Giovannoni

  2. Personalized medicine in multiple sclerosis

    Article • Neurodegenerative Disease Management, November 2017, Future Medicine

    Gavin Giovannoni

  3. Circulating lymphocyte levels and relationship with infection status in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta

    Article • Multiple Sclerosis Journal, September 2017, SAGE Publications

    Gavin Giovannoni

  4. Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

    Article • Multiple Sclerosis Journal, September 2017, SAGE Publications

    Gavin Giovannoni

  5. Can we afford not to prevent MS-related disability?

    Article • Multiple Sclerosis Journal, May 2017, SAGE Publications

    Gavin Giovannoni

  6. “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis

    Article • Multiple Sclerosis Journal, April 2017, SAGE Publications

    Gavin Giovannoni

  7. Multiple sclerosis should be treated using a step-down strategy rather than a step-up strategy–YES

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Gavin Giovannoni

  8. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

    Article • Multiple Sclerosis Journal, February 2015, SAGE Publications

    Gavin Giovannoni, prof aksel siva